Viewing Study NCT00115973



Ignite Creation Date: 2024-05-05 @ 11:44 AM
Last Modification Date: 2024-10-26 @ 9:12 AM
Study NCT ID: NCT00115973
Status: COMPLETED
Last Update Posted: 2016-10-18
First Post: 2005-06-26

Brief Title: A Study of the Treatment of Type 2 Diabetes With an Insulin Infusion Pump
Sponsor: Novo Nordisk AS
Organization: Novo Nordisk AS

Study Overview

Official Title: An Open-Label Stepwise Basal Insulin Dose Titration Study Using Continuous Subcutaneous Insulin Infusion CSII in Oral Antidiabetic Drug-Treated Type 2 Diabetes Mellitus Subjects Followed by a 10-Week Out-Patient Maintenance Phase
Status: COMPLETED
Status Verified Date: 2016-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This trial is conducted in the United States of America USA This is an in-patient trial investigating stepwise dose increase in a period of up to 3-weeks followed by a 10-week out-patient maintenance period A telephone contact visit is scheduled as a follow-up for the final clinic visit A subjects participation in this trial would be expected to be up to 16 weeks
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None